Padma Sundar

2020

In 2020, Padma Sundar earned a total compensation of $908.4K as Senior Vice President, Marketing and Market Access at Oncocyte Corp, a 17% increase compared to previous year.

Compensation breakdown

Bonus$60,000
Change in Pension Value and Nonqualified Deferred Compensation Earnings$297
Option Awards$543,150
Salary$293,260
Other$11,665
Total$908,372

Sundar received $543.2K in option awards, accounting for 60% of the total pay in 2020.

Sundar also received $60K in bonus, $297 of change in pension value and nonqualified deferred compensation earnings, $293.3K in salary and $11.7K in other compensation.

Rankings

In 2020, Padma Sundar's compensation ranked 9,017th out of 13,090 executives tracked by ExecPay. In other words, Sundar earned more than 31.1% of executives.

ClassificationRankingPercentile
All
9,017
out of 13,090
31st
Division
Manufacturing
3,853
out of 5,621
32nd
Major group
Chemicals And Allied Products
1,558
out of 2,254
31st
Industry group
Drugs
1,361
out of 1,954
30th
Industry
In Vitro and In Vivo Diagnostic Substances
35
out of 60
42nd
Source: SEC filing on May 21, 2021.

Sundar's colleagues

We found three more compensation records of executives who worked with Padma Sundar at Oncocyte Corp in 2020.

2020

Albert Parker

Oncocyte Corp

Chief Operating Officer

2020

Mitchell Levine

Oncocyte Corp

Chief Financial Officer

2020

Ronald Andrews

Oncocyte Corp

Chief Executive Officer

News

In-depth

You may also like